Jubilant Biosys Strengthens Leadership with Somesh Sharma as COO of Drug Discovery Services
核心洞察
Jubilant Biosys (搜索) has appointed Somesh Sharma, PhD, MBA, as its new Chief Operating Officer for Drug Discovery Services, bringing over three decades of pharmaceutical and life sciences leadership experience.
In his new role, Sharma will oversee Jubilant Biosys (搜索)'s Drug Discovery operations, with the company expecting his expertise to strengthen scientific excellence and expand operational capabilities.
The appointment aims to increase the value delivered to customers and partners worldwide, reinforcing the company's position in the drug discovery services sector.
Jubilant Biosys (搜索) has announced the appointment of Somesh Sharma, PhD, MBA, as its new Chief Operating Officer for Drug Discovery Services, a move the company says is intended to strengthen scientific excellence and expand its operational capabilities across the drug discovery value chain.
Sharma joins the organization with more than three decades of leadership experience in the pharmaceutical and life sciences sector. Over the course of his career, he has built a reputation for driving operational excellence, steering strategic growth, and fostering customer-centric innovation. He has led complex organizations, assembled high-performing teams, and delivered measurable business results across discovery, development, and manufacturing services.
In his new position, Sharma will oversee Jubilant Biosys (搜索)'s Drug Discovery operations. The company stated that his industry expertise is expected to strengthen scientific excellence, expand operational capabilities, and increase the value delivered to customers and partners around the world.
Jubilant Biosys (搜索) welcomed Sharma to the organization, expressing confidence in the leadership, expertise, and vision he brings to the company. Leadership at the company said they look forward to achieving new milestones together as he settles into his new role.
The appointment reflects the broader strategic direction of Jubilant Biosys (搜索), which has also recently expanded Jay Sheth's leadership mandate as Head of CDMO, North America. The company noted that pharmaceutical and biotechnology companies are increasingly seeking integrated partners across the drug development value chain, positioning Jubilant Biosys to strengthen its relationships with biopharma companies, emerging biotech firms, and investment communities in North America and other global markets.